CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Cash flows from operating activities:
Net income	$ 25,001	$ 21,722
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	211,843	203,392
Share-based compensation expense	7,135	7,828
Income from unconsolidated joint venture	(1,223)	(1,456)
Distributions from unconsolidated joint venture	2,455	2,225
(Gain) loss on sale of real estate, net	(1,991)	37
Loss on extinguishment of debt, net	27,726	21,646
Changes in operating assets and liabilities:
Receivables and other assets, net	3,282	(2,148)
Accounts payable and accrued liabilities	(11,787)	(19,783)
Security deposits, prepaid rent and other liabilities	7,227	4,919
Net cash provided by operating activities	269,668	238,382
Cash flows from investing activities:
Investments in real estate	(52,553)	(223,168)
Development of real estate	(49,479)	(14,253)
Proceeds from the sale of real estate	6,420	1,193
Capital expenditures	(59,016)	(59,533)
Collection of real estate notes receivable	709	551
Advances on real estate notes receivable	(6,000)	0
Net cash used in investing activities	(159,919)	(295,210)
Cash flows from financing activities:
Borrowings on unsecured revolving credit facility	1,329,862	365,000
Payments on unsecured revolving credit facility	(1,429,862)	(350,000)
Proceeds from unsecured senior notes	793,568	906,927
Payments from unsecured senior notes	(300,000)	(700,000)
Payments on secured mortgage loans	(114,060)	(96,765)
Deferred financing costs	(6,532)	(6,954)
Debt extinguishment costs	(25,938)	(18,383)
Proceeds from issuance of common stock	50,020	51,804
Issuance of OP Units	1,378	0
Repurchase and cancellation of common stock	(5,094)	(12,159)
Dividends paid	(205,880)	(190,853)
Distributions paid to noncontrolling interest of limited partners	(3,581)	(7,503)
Net cash provided by (used in) financing activities	83,881	(58,886)
Net change in cash, cash equivalents and restricted cash	193,630	(115,714)
Cash, cash equivalents and restricted cash - beginning of period	37,616	133,530
Cash, cash equivalents and restricted cash - end of period	231,246	17,816
Healthcare Trust of America Holdings, LP (HTALP)
Cash flows from operating activities:
Net income	25,001	21,722
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	211,843	203,392
Share-based compensation expense	7,135	7,828
Income from unconsolidated joint venture	(1,223)	(1,456)
Distributions from unconsolidated joint venture	2,455	2,225
(Gain) loss on sale of real estate, net	(1,991)	37
Loss on extinguishment of debt, net	27,726	21,646
Changes in operating assets and liabilities:
Receivables and other assets, net	3,282	(2,148)
Accounts payable and accrued liabilities	(11,787)	(19,783)
Security deposits, prepaid rent and other liabilities	7,227	4,919
Net cash provided by operating activities	269,668	238,382
Cash flows from investing activities:
Investments in real estate	(52,553)	(223,168)
Development of real estate	(49,479)	(14,253)
Proceeds from the sale of real estate	6,420	1,193
Capital expenditures	(59,016)	(59,533)
Collection of real estate notes receivable	709	551
Advances on real estate notes receivable	(6,000)	0
Net cash used in investing activities	(159,919)	(295,210)
Cash flows from financing activities:
Borrowings on unsecured revolving credit facility	1,329,862	365,000
Payments on unsecured revolving credit facility	(1,429,862)	(350,000)
Proceeds from unsecured senior notes	793,568	906,927
Payments from unsecured senior notes	(300,000)	(700,000)
Payments on secured mortgage loans	(114,060)	(96,765)
Deferred financing costs	(6,532)	(6,954)
Debt extinguishment costs	(25,938)	(18,383)
Proceeds from issuance of general partner units	50,020	51,804
Issuance of OP Units	1,378	0
Repurchase and cancellation of general partner units	(5,094)	(12,159)
Distributions paid to general partner	(205,880)	(190,853)
Distributions paid to limited partners and redeemable noncontrolling interests	(3,581)	(7,503)
Net cash provided by (used in) financing activities	83,881	(58,886)
Net change in cash, cash equivalents and restricted cash	193,630	(115,714)
Cash, cash equivalents and restricted cash - beginning of period	37,616	133,530
Cash, cash equivalents and restricted cash - end of period	$ 231,246	$ 17,816